ChanRx Obtains New Financing Round Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=cab9e67d-260e-4544-af3b-859c342ed807&Preview=1 Date 11/21/2011 Company Name ChanRx Mailing Address Undisclosed Garfield Heights, OH 44105 Company Description The company is developing small molecule drugs to treat atrial fibrillation. Website Undisclosed Transaction Type Venture Equity Transaction Amount Undisclosed Transaction Round Undisclosed Proceeds Purposes The company, a spin out of Cleveland-based ChanTest, will use the funding to further evaluate the safety and efficacy of its proprietary AFIB drug, vanoxerine. M&A Terms Venture Investor Sante Ventures